Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Human Acute Leukemia Is Addicted to Branched-Chain Amino Acid Metabolism to Maintain Leukemia Stemness

Yoshikane Kikushige, MD PhD, Toshihiro Miyamoto, MD PhD, Takahiro Maeda, MD PhD, Koichi Akashi, MD PhD

Blood (2019) 134 (Supplement_1): 2516.

https://doi.org/10.1182/blood-2019-129372

Published: 2019

Journal Articles

Acceleration of AML Progression By Cigarette Smoke Exposure or Condensate Exposure and Associated DNA Methylation Alterations

Mary Figueroa, BS, Mansour Alfayez, MD, Yue Lu, PhD, Marcos Estecio, PhD, Seyed Javad Moghaddam, MD, Marina Y Konopleva, MD PhD, Elias Jabbour, MD, Courtney D. DiNardo, MDMSc, Joya Chandra, PhD

Blood (2019) 134 (Supplement_1): 2554.

https://doi.org/10.1182/blood-2019-127216

Published: 2019

Journal Articles

Activated Leukocyte Cell Adhesion Molecule (ALCAM) Regulate Myeloma Cancer Stem Cell Mediated Myelomagenesis and Chemoresistance

Yuhuan Zheng, Hongmei Luo, Dan Zhang, Fangfang Wang

Blood (2018) 132 (Supplement 1): 3190.

https://doi.org/10.1182/blood-2018-99-111740

Published: 2018

Journal Articles

Bortezomib-Activated Macrophages Contribute to Multiple Myeloma Progression Via Cancer Stem Cell Enrichment

Ofrat Beyar Katz, MD, Ksenia Magidey Klein, M.Sc, Michael Timaner, PhD, Ziv Raviv, PhD, Noam Benyamini, MD, Benjamin Brenner, MD, Yuval Shaked, PhD

Blood (2017) 130 (Supplement 1): 2269.

https://doi.org/10.1182/blood.V130.Suppl_1.2269.2269

Published: 2017

Journal Articles

Identification of Novel Targets for Antibody or Chimeric Antigen Receptor (CAR) Based Immunotherapy in AML: Characterizing the Surfaceome from Primary Patient Samples

Thomas Koehnke, MD, Liu Xilong, Sascha Haubner, MD, Christina Krupka, PhD, Victor Solis-Mezarino, Franz Herzog, PhD, Wolfgang Hiddemann, MD PhD, Marion S. Subklewe, MD

Blood (2017) 130 (Supplement 1): 3968.

https://doi.org/10.1182/blood.V130.Suppl_1.3968.3968

Published: 2017

Journal Articles

A Novel Humanised ROR1 Bi-Specific T-Cell Engager Molecule for the Treatment of Chronic Lymphocytic Leukaemia

Satyen Harish Gohil, MBBS MRCP FRCPath, Micaela Harrasser, Solange R Paredes-Moscosso, Amit C Nathwani, MD PhD, Marco Della Peruta, PhD

Blood (2016) 128 (22): 3244.

https://doi.org/10.1182/blood.V128.22.3244.3244

Published: 2016

Journal Articles

Engineering of Trispecific Molecule That Induces Natural Killer Cell Expansion While Mediating CD133-Specific Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)

Jörg Uwe Schmohl, MD, Martin Felices, PhD, Jeffrey S. Miller, MD, Dan Vallera, PhD

Blood (2016) 128 (22): 3518.

https://doi.org/10.1182/blood.V128.22.3518.3518

Published: 2016

Journal Articles

A Phase I/II Clinical Trial of the First-in-Class GPCR Antagonist ONC201 in Relapsed/Refractory Acute Leukemias

Gautam Borthakur, MD, Jo Ishizawa, MD PhD, Courtney D DiNardo, MD, Tapan M. Kadia, MD, Katherine Weise, Joshua E Allen, PhD, Wolfgang Oster, MD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Michael Andreeff, MD PhD

Blood (2016) 128 (22): 3997.

https://doi.org/10.1182/blood.V128.22.3997.3997

Published: 2016

Journal Articles

Novel ROR1 Antibody Is Able to Trigger Specific and Superior Complement-Dependent Cytotoxicity (CDC) on Primary CLL Cells

Solange R Paredes-Moscosso, Marco Della Peruta, PhD, Satyen Harish Gohil, MBBS MRCP FRCPath, Micaela Harrasser, Amit C Nathwani, MD PhD

Blood (2016) 128 (22): 2052.

https://doi.org/10.1182/blood.V128.22.2052.2052

Published: 2016

Journal Articles

Multiple Myeloma Cancer Stem Cells: Immunophenotypic and Functional Characterization, Gene Expression Profiling and Therapeutic Targets

Mariana Bleker de Oliveira, BSc, Paola Marino Dantonio, BSc, Veruska Lia Fook Alves, PhD, Rodrigo Carlini Fernando, BSc, Daniela Teixeira, MSc, Alexandre Basso, PhD, Mihoko Yamamoto, MD PhD, Gisele W. B. Colleoni, MD PhD

Blood (2016) 128 (22): 4434.

https://doi.org/10.1182/blood.V128.22.4434.4434

Published: 2016

Journal Articles

Distress and Perceived Impact on Well-Being for Low- or Intermediate-Risk and High-Risk Patients with Chronic Lymphocytic Leukemia (CLL)

Joanne S. Buzaglo, PhD, Melissa F. Miller, PhD MPH, Clare Karten, MS, Elisa S Weiss, PhD, Brian Tomlinson, MPA, BSW, Barbara L Andersen, PhD, Matthew J Matasar, MD MS, John C. Byrd, MD, Christopher Flowers, MD MS

Blood (2016) 128 (22): 5970.

https://doi.org/10.1182/blood.V128.22.5970.5970

Published: 2016

Journal Articles

Tracking Normal and Chronic Myeloid Leukemia Progenitor Cell Cycle Kinetics in a Defined Niche Using Live Time Lapse Confocal Imaging with Fucci2BL a Novel Lentiviral Bicistronic Reporter

Gabriel Pineda, PhD, Kathleen M Lennon, BS, Nathaniel P Delos-Santos, BS, Florence Lambert-Fliszar, Gennarina L Riso, BS, Marco A Marra, PhD, Sheldon Morris, MD, Asako Sakaue-Sawano, PhD, Atsushi Miyawaki, PhD, Catriona HM Jamieson, MD PhD

Blood (2015) 126 (23): 1863.

https://doi.org/10.1182/blood.V126.23.1863.1863

Published: 2015

Journal Articles

In silico Tissue-Based Expression Analysis of YY1 and Cancer Stem Cell (CSC) Transcription Factors in Hematological Malignancies: Unraveling New Therapeutic Targets

Samantha Kaufhold, Hermes Garban, MD PhD, Benjamin Bonavida, PhD

Blood (2015) 126 (23): 4814.

https://doi.org/10.1182/blood.V126.23.4814.4814

Published: 2015

Journal Articles

Inflammatory Cytokine-Responsive ADAR1 Impairs Let-7 Biogenesis and Promotes Leukemia Stem Cell Generation

Maria Anna Zipeto, PhD, Angela Court Recart, Nathaniel Delos Santos, Qingfei Jiang, PhD, Leslie A Crews, PhD, Catriona HM Jamieson, MD PhD

Blood (2015) 126 (23): 4014.

https://doi.org/10.1182/blood.V126.23.4014.4014

Published: 2015

Journal Articles

Targeting Plasticity and Stemness in Multiple Myeloma Tumor Cells

Stacy W. Blain, PhD, Danielle Joseph, Amitabha Mazumder, MD

Blood (2015) 126 (23): 4270.

https://doi.org/10.1182/blood.V126.23.4270.4270

Published: 2015

Journal Articles

Identification of a CLL Cancer Stem Cell

Joshua Kellner, PhD, Eric Yvon, PhD, Veronica Gordon, Ian K. McNiece, PhD

Blood (2015) 126 (23): 5401.

https://doi.org/10.1182/blood.V126.23.5401.5401

Published: 2015

Journal Articles

Targeting Cancer Stem Cell Survival in Plasma Cell Leukemia with a Pan-BCL2 Inhibitor

Elisa Lazzari, MA, Leslie A Crews, PhD, Christina Wu, PhD, Heather Leu, BS, Raffaella Chiaramonte, PhD, Mark D. Minden, MD PhD, Caitlin L. Costello, MD, Catriona Jamieson, MD PhD

Blood (2015) 126 (23): 5351.

https://doi.org/10.1182/blood.V126.23.5351.5351

Published: 2015

Journal Articles

Multiple Myeloma Patient Experience with Financial Toxicity: Findings from the Cancer Experience Registry

Joanne S. Buzaglo, PhD, Melissa F. Miller, PhD MPH, Clare Karten, MS, Margaret Longacre, PhD, Victoria Kennedy, MSW, LCSW, Thomas W. LeBlanc, MD MA

Blood (2015) 126 (23): 874.

https://doi.org/10.1182/blood.V126.23.874.874

Published: 2015

Journal Articles

The Financial Costs of Chronic Myeloid Leukemia and Implications for Quality of Life and Adherence: Findings from the Cancer Experience Registry

Joanne S. Buzaglo, PhD, Clare Karten, MS, Elisa Weiss, PhD, Melissa F. Miller, PhD, Anne Morris, MPH

Blood (2014) 124 (21): 2602.

https://doi.org/10.1182/blood.V124.21.2602.2602

Published: 2014

Journal Articles

ONC201 Depletes Cancer Stem Cells in Refractory Cancer Patient Samples

Varun Vijay Prabhu, Jo Ishizawa, MD PhD, Dan Zhao, MD PhD, Joshua E. Allen, PhD, Tracy T. Batchelor, MD, Andrew S. Chi, MD PhD, Michael Andreeff, MD PhD, Wafik S. El-Deiry, MD PhD F.A.C.P

Blood (2014) 124 (21): 5219.

https://doi.org/10.1182/blood.V124.21.5219.5219

Published: 2014

NARROW

Human Acute Leukemia Is Addicted to Branched-Chain Amino Acid Metabolism to Maintain Leukemia Stemness

Acceleration of AML Progression By Cigarette Smoke Exposure or Condensate Exposure and Associated DNA Methylation Alterations

Activated Leukocyte Cell Adhesion Molecule (ALCAM) Regulate Myeloma Cancer Stem Cell Mediated Myelomagenesis and Chemoresistance

Bortezomib-Activated Macrophages Contribute to Multiple Myeloma Progression Via Cancer Stem Cell Enrichment

Identification of Novel Targets for Antibody or Chimeric Antigen Receptor (CAR) Based Immunotherapy in AML: Characterizing the Surfaceome from Primary Patient Samples

A Novel Humanised ROR1 Bi-Specific T-Cell Engager Molecule for the Treatment of Chronic Lymphocytic Leukaemia

Engineering of Trispecific Molecule That Induces Natural Killer Cell Expansion While Mediating CD133-Specific Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)

A Phase I/II Clinical Trial of the First-in-Class GPCR Antagonist ONC201 in Relapsed/Refractory Acute Leukemias

Novel ROR1 Antibody Is Able to Trigger Specific and Superior Complement-Dependent Cytotoxicity (CDC) on Primary CLL Cells

Multiple Myeloma Cancer Stem Cells: Immunophenotypic and Functional Characterization, Gene Expression Profiling and Therapeutic Targets

Distress and Perceived Impact on Well-Being for Low- or Intermediate-Risk and High-Risk Patients with Chronic Lymphocytic Leukemia (CLL)

Tracking Normal and Chronic Myeloid Leukemia Progenitor Cell Cycle Kinetics in a Defined Niche Using Live Time Lapse Confocal Imaging with Fucci2BL a Novel Lentiviral Bicistronic Reporter

In silico Tissue-Based Expression Analysis of YY1 and Cancer Stem Cell (CSC) Transcription Factors in Hematological Malignancies: Unraveling New Therapeutic Targets

Inflammatory Cytokine-Responsive ADAR1 Impairs Let-7 Biogenesis and Promotes Leukemia Stem Cell Generation

Targeting Plasticity and Stemness in Multiple Myeloma Tumor Cells

Identification of a CLL Cancer Stem Cell

Targeting Cancer Stem Cell Survival in Plasma Cell Leukemia with a Pan-BCL2 Inhibitor

Multiple Myeloma Patient Experience with Financial Toxicity: Findings from the Cancer Experience Registry

The Financial Costs of Chronic Myeloid Leukemia and Implications for Quality of Life and Adherence: Findings from the Cancer Experience Registry

ONC201 Depletes Cancer Stem Cells in Refractory Cancer Patient Samples

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only